KAI Shorts Creep Back After Q3 Print

Kadant has just reported Q3 earnings, and the short-side picture has shifted modestly in the days around the event: bears who spent October covering are now adding back positions, though the move is too small to change the broader narrative.

Short interest ticked up 2.9% on the week to 903,744 shares, or 7.7% of the free float. That is a reversal of direction after a month that saw shorts unwind roughly 8%. To put the current level in context, the peak was above 1 million shares in late September. Bears have not rebuilt anything close to that position. The borrow market confirms the lack of urgency: cost to borrow has actually fallen 7% over the week to 0.45%, and availability is running at 458%, meaning there are roughly four and a half shares available to borrow for every one already shorted. That is generous capacity. The modest tightening from last week's 481% simply reflects the small rise in short interest, not any squeeze dynamic. The lending market is relaxed.

Options positioning is similarly calm. The put/call ratio of 1.0 is modestly above its 20-day mean of 0.856, but the z-score of 0.63 is barely half a standard deviation above average. That is not a hedge signal worth flagging. The 52-week range on the PCR runs from 0.25 to 2.71, and the current reading is squarely in the middle third. The ORTEX short score has drifted up from 53.0 on October 23 to 55.4 today, a direction worth watching but not yet meaningful as a standalone signal.

The Street is split rather than decisive. Barrington Research holds an Outperform with a $380 target, implying about 34% upside from the current $282.79. DA Davidson is more cautious at Neutral, raising its target to $335 in August. The mean analyst target of $357.50 represents roughly 26% implied upside, though analyst activity has been sparse in recent months. Valuation multiples have been drifting: the P/E has compressed roughly 5% over the past 30 days to 19.8x, and EV/EBITDA has edged down to 12.1x over the same period. The earnings yield factor scores in the 52nd percentile, unexceptional, while forward EPS growth year-on-year ranks in the 90th percentile, the strongest single factor on the sheet. The bear case centres on margin pressure from tariffs and an unfavourable product mix; the bull case rests on aftermarket parts demand, which made up 73% of total revenue in the most recent quarter.

One institutional footnote worth noting: Goldman Sachs Asset Management added 176,619 shares as of October 1, a meaningful build for a name of this size. BlackRock remains the dominant holder at 15.2% and added 62,069 shares in Q3. No 13D activist is on the register. The Schedule 13G/A filings are passive disclosures; stakes are as last disclosed around the 5% threshold, and holders dropping below that level may not file again.

Wikipedia page traffic has surged to a z-score of 3.0 against Kadant's own 90-day history, the highest retail attention reading the alt-data layer captures. It is a colour signal, not a revenue indicator, but it does suggest the Q3 print has drawn more eyes to the stock than usual. The next scheduled earnings event is February 16, 2027, so the near-term calendar is clear.

The question now is whether the modest short rebuild around the earnings event reflects bears re-engaging on the thesis or simply mechanical repositioning after a period of covering. With borrow costs low and availability abundant, the data gives no clean answer either way.